Palleos Healthcare has a distinguished history of advancing medical innovations, leveraging its extensive experience and network to accelerate the development of new therapies. By integrating academic ...

Scorpius Holdings partners with biotech firm to expand U.S.-based biomanufacturing capabilities for innovative biologics ...

Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy ...

DelveInsight's 'JAK Inhibitors Pipeline Insight 2024' report provides comprehensive global coverage of pipeline JAK ...

The FDA mandate to increase diversity in clinical trials fails to address critical issues in treatment for Black women, according to experts.

The positive results from the double-blind period of the RISE UP Phase 2 study, which were presented at the 65 th American Society of Hematology (ASH) Annual Meeting & Exposition in December 2023, ...

Discover the applications of Ttau PFFs and alpha-synuclein PFFs in advancing neurodegenerative disease research.

An Alzheimer's drug deemed the "best ever" is set to be blocked for NHS use due to its high cost. Donanemab, manufactured by ...

Donanemab, manufactured by pharmaceutical giant Eli Lilly, is a targeted antibody drug which slows down the early stages of Alzheimer's. It was approved by the medicines regulator on Wednesday, but ...

Link Financial Group (LFG) is delighted to announce its inclusion in the prestigious 2024 NZ Adviser Top Mortgage Employers list, recognising the best in the industry. NZ adviser, an impartial leader ...

Alpha-9 Oncology has raised a $175 million series C round to bankroll its clinical-stage radiopharmaceutical drugs, although ...